Flagship explainer
What drives Pyxis Oncology, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$79.6M | FY2025 |
| |
| Income before tax | −$78.2M | FY2025 |
|
| Operating income | −$84.4M | FY2025 |
|
| $13.9M | FY2025 |
| |
| Ending assets | $91.5M | FY2025 |
|
| Beginning assets | $157M | FY2024 |
|
| $53.4M | FY2025 |
| |
| $121M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-118532